Nanosonics

Nanosonics EBIT Margin

The EBIT Margin (Operating Margin) of Nanosonics (NAN.AX) as of Oct 28, 2026 is 7.37 %. In the previous year, EBIT Margin (Operating Margin) was 4.49 % — a change of 64.17% (higher).

EBIT Margin

7.37 %

YoY

64.17%

Last updated:

EBIT Margin (Operating Margin) of Nanosonics is 2026 7.37 % . EBIT Margin (Operating Margin) of Nanosonics was 2025 4.49 % . It decreases by 64.17% higher compared to the previous year.

Nanosonics's operating (EBIT) margin stands at 7.4%, up from 0.7% several years earlier.

The Nanosonics EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2019
16.20 AUD
Jan 1, 2020
12.09 AUD
Jan 1, 2021
8.23 AUD
Jan 1, 2022
0.66 AUD
Jan 1, 2023
10.74 AUD
Jan 1, 2024
5.31 AUD
Jan 1, 2025
4.49 AUD
Jan 1, 2026
7.37 AUD
The Nanosonics EBIT Margin history
YEAREBIT MarginYoY
7.37 %+64.17%
4.49 %-15.56%
5.31 %-50.54%
10.74 %+1,524.30%
0.66 %-91.96%
8.23 %-31.93%
12.09 %-25.37%
16.20 %+249.55%
4.63 %-76.17%
19.45 %-2,349.66%
-0.86 %-97.17%
-30.53 %+132.71%
-13.12 %+2,083.78%
-0.60 %+6.19%
-0.57 %-90.91%
-6.22 %-51.98%
-12.96 %-61.93%
-34.04 %+262.42%
-9.39 %-99.09%
-1,036.19 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Nanosonics Stock analysis

What does Nanosonics do? Nanosonics Ltd is an Australian company specializing in the development of innovative disinfectants designed specifically for use in medical facilities. The company was founded in 2000 by two scientists, Ron Weinberger and Kelvin Trautman, with the aim of reducing the spread of infections through medical devices and equipment. Nanosonics developed a new disinfectant based on the use of ultrasound to achieve higher effectiveness. Its first product, the Trophon EPR, was launched in 2007 and was the world's first Dry Chemical Disinfection system specifically designed for ultrasound probes. Nanosonics has since expanded its product line to include the Trophon2, an improved version of the Trophon EPR, and Ultra, a hand sanitizer for use in medical facilities. It has also developed the TRISTEL Duo disinfection system for flexible endoscopes. Nanosonics is focused on sustainable growth and works closely with customers to develop products tailored to their specific needs. The company is headquartered in Sydney, Australia, with branches in Europe and North America to support global expansion. Technological innovation and collaboration with customers have helped Nanosonics establish itself as a leading provider of disinfection solutions for medical facilities, ensuring patient safety and infection control. Nanosonics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Nanosonics stock

EBIT Margin (Operating Margin) of Nanosonics is 7.37 % in 2026.

EBIT Margin (Operating Margin) of Nanosonics changed from 4.49 % to 7.37 %, representing a 64.17% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Nanosonics since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Nanosonics with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Nanosonics

All Key Metrics — Nanosonics